Wegovy is targeted at adults with a BMI of 30 kg/m or higher (classified as obesity) or those with a BMI of 27 kg/m or higher (classified as overweight) who have at least one weight-related health condition
Phase 3 TRIUMPH-1 Trial Results (2026 Update) TRIUMPH-1 is the pivotal Phase 3 obesity trial for retatrutide
Finally, underlying medical issues such as hormonal imbalances, vitamin and mineral deficiencies, thyroid problems, or interactions with other medications can also contribute to ongoing hunger
However, patient feedback on provider quality varies, some visits praised and others criticized for feeling rushed
Liked by Chris Aiken, MD I worry about light-at-night and #sleep
I would not change the dosage or stop a GLP1-RA in the setting of arrhythmias or palpitations, Dr